← back to search

Christian Garzoni

Università della Svizzera italiana · CH
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Cytomegalovirus and herpesvirus research, COVID-19 Clinical Research Studies, and Antifungal resistance and susceptibility.
h-index
46
citations
11,696
works
157
NIH funding
primary concept
Medicine
email

Recent publications

Neutralization, effector function and immune imprinting of Omicron variants
Nature 2023cited by 178position: middledoi
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Science Immunology 2023cited by 87position: middledoi
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein.
2023cited by 71position: contributordoi
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
2023cited by 19position: contributordoi
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Science 2022cited by 183position: middledoi
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies.
2022cited by 170position: contributordoi
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2
Gut Microbes 2022cited by 72position: middledoi
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature 2022cited by 3position: middledoi
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Nature 2021cited by 1,200position: middledoi
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature 2021cited by 713position: middledoi
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
Cell 2021cited by 655position: middledoi
Broad betacoronavirus neutralization by a stem helix–specific human antibody
Science 2021cited by 429position: middledoi
Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study
European Respiratory Journal 2021cited by 423position: middledoi
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.
2021cited by 408position: contributordoi
Broad betacoronavirus neutralization by a stem helix-specific human antibody.
2021cited by 403position: contributordoi
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Nature 2021cited by 213position: middledoi
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Cell 2020cited by 1,623position: middledoi
Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study
Clinical Infectious Diseases 2017cited by 121position: middledoi
<i>Nocardia</i>Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study
Clinical Infectious Diseases 2016cited by 254position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marco Mancinetti · University of Fribourg1 papers (2021–2021)Yok‐Ai Que · University of Bern1 papers (2021–2021) · 1 papers (2022–2022) · 1 papers (2022–2022)Maura Prella · University of Lausanne1 papers (2021–2021) · 1 papers (2022–2022) · 1 papers (2021–2021)Lise Piquilloud · University of Lausanne1 papers (2021–2021)Ujjwal Neogi · Karolinska Institutet1 papers (2022–2022)Jérôme Pugin · Shanghai Jiao Tong University1 papers (2022–2022)Lukas Ebner · University Hospital of Bern1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2022–2022) · 1 papers (2021–2021)Tarini Shankar Ghosh · APC Microbiome Institute1 papers (2022–2022) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2022–2022)Christophe von Garnier · University of Bern1 papers (2021–2021)Andreas Cerny · University of Lausanne1 papers (2022–2022)